Full Breakdown
Sony Pulls U.S. Distribution of *The Salt Path* Amid Memoir Controversy
8/19/2026, 2:07:17 AM
Core Event
In summer 2025 Sony Pictures withdrew from a planned U.S. and Canada distribution deal for *The Salt Path*, a film adaptation of Raynor and Moth Winn’s 2018 memoir. The decision followed a U.K. Observer investigation that alleged key elements of the memoir were misrepresented, including the circumstances of the couple’s home loss and the diagnosis of Moth Winn’s terminal neurological disease. The withdrawal was announced the week the cast were finalising the deal, prompting lead actress Gillian Anderson to call the episode “a huge letdown” and “a betrayal” after the cast had spent time with the Winns.
Background & Context
*The Salt Path* recounts how Ray and Moth Winn, after losing their Welsh home, walked the 630-mile South West Coast Path while Moth battled corticobasal degeneration (CBD). The memoir sold over two million copies worldwide and was adapted for the screen with Anderson as Ray and Jason Isaacs as Moth. The film earned £7.6 million in the United Kingdom, becoming one of 2025’s most successful British indie releases.
The Observer’s investigation challenged the memoir’s factual basis, claiming Ray Winn (legal name Sally Walker) had taken a loan to repay alleged theft from a former employer, Martin Hemmings, and that the couple owned land in France, contradicting the narrative of total homelessness. The newspaper also questioned the authenticity of Moth’s CBD diagnosis. The Winns denied the allegations, calling the report “highly misleading” and “grotesquely unfair.”
Official Statements & Responses
- Kelly Rogers, CEO of Rialto Distribution International, reiterated his earlier praise of the film as “a film of quiet power” and emphasized Rialto’s commitment to releasing the movie in North America on the rescheduled date.
- Sony did not provide a comment to *Variety* or other outlets at the time of the withdrawal.
Data & Statistics
- Memoir sales: > 2 million copies worldwide.
- UK box office: £7.6 million.
- Original U.S./Canada release date: May 22 2025 (scheduled).
- Rescheduled U.S./Canada release date: September 4 2025 (scheduled).
Impact & Next Steps
The distribution shift delayed the film’s North American debut by several months, moving the release from May 22 to September 4. Rialto’s CEO highlighted the film’s themes of love and endurance as reasons to proceed despite the controversy. The author’s forthcoming fourth non-fiction title, *On Winter Hill*, was postponed from October 2025 to January 2028 after the scandal caused “considerable distress” for Raynor Winn.
Conflicting Reports & Gaps
- Home loss: The Observer alleges the Winns lost their house after Ray embezzled money and borrowed ~£100,000 from a family member; Winn maintains the loss resulted from a disputed business dispute with Martin Hemmings.
- Medical diagnosis: The Observer questions the validity of Moth’s CBD diagnosis, while the memoir and film present it as a confirmed terminal condition. No medical records have been publicly released to verify either claim.
Verbatim Quotes
- “This is a film of quiet power,” — Kelly Rogers, Rialto CEO
The controversy underscores the challenges of adapting purportedly true stories for the screen when the factual foundation is later called into question.
